PARIS & NEW YORK--(BUSINESS WIRE)--Inato, the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and ...
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation. The raise included returning investor Obvious Ventures and new participants La Maison and Top ...
NEW YORK and SAN ANTONIO, Sept. 23, 2025 /PRNewswire/ -- Today, Inato and RealTime eClinical Solutions announced a partnership to enhance site selection and trial enrollment. The partnership will ...
Almost three-quarters of all clinical trials are run by the same 5% of academic sites, according to Inato CEO Kourosh Davarpanah. “This lack of patient access causes trial delays and costs to ...
NEW YORK and PARIS, Jan. 28, 2025 /PRNewswire/ -- Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen ...
Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. Launched in ...
Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. Treating artificial intelligence as just one ingredient in a ...
Pharma companies have traditionally relied on the same large academic centers to run their clinical trials, with the top 5% of research sites accounting for about 70% of trials. There are hundreds of ...
Inato and RealTime eClinical Solutions have announced a partnership aimed at improving trial site selection and subject enrolment. This collaboration merges RealTime-Devana's TrialAlign site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results